Department of Applied Psychology, Zurich University of Applied Sciences, Zurich, Switzerland.
Department of Inpatient Psychotherapy and Crisis Intervention, University Clinic for Psychiatry, Psychotherapy, and Psychosomatics, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria.
Crisis. 2024 May;45(3):225-233. doi: 10.1027/0227-5910/a000941. Epub 2024 Feb 14.
Previous ecological studies reported that increasing antidepressant prescriptions were associated with decreasing suicide rates. To determine whether antidepressant prescription prevalence is negatively associated with suicide rates (i.e., as antidepressant prescribing increases, suicide rates decrease) between 1999 and 2020. The study protocol was pre-registered on the Open Science Framework (https://osf.io/978sk/). Publicly available data from the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) and Medical Expenditure Panel Survey (MEPS) were used. Overall, both the antidepressant prescription prevalence and the suicide rate were increasing from 1990 to 2020 in the United States. Positive trends for both outcomes were also evident when analyses were stratified according to sex and/or race/ethnicity. Pearson's correlation analyses consistently found positive associations between antidepressant prescription prevalence and suicide rates. Trends and their associations were examined at the population level. The results cannot clarify the causal nature of the association observed. The results of our analysis consistently demonstrated positive trends for both antidepressant prescription prevalence and suicide rates over time as well as positive associations between them. These findings update those from previous studies and are at odds with the notion that, at a population level, more antidepressant prescriptions would lead to lower suicide rates. However, it needs to be acknowledged that ecological studies provide insufficient evidence to infer causality.
先前的生态学研究报告称,抗抑郁药处方的增加与自杀率的降低有关。本研究旨在确定在 1999 年至 2020 年期间,抗抑郁药处方的流行率是否与自杀率呈负相关(即随着抗抑郁药的开具增加,自杀率下降)。该研究方案已在开放科学框架(https://osf.io/978sk/)上预先注册。本研究使用了美国疾病控制与预防中心的广泛在线数据进行流行病学研究(CDC WONDER)和医疗支出面板调查(MEPS)中公开提供的数据。总体而言,在美国,从 1990 年到 2020 年,抗抑郁药的处方流行率和自杀率都在上升。当根据性别和/或种族/民族对这两种结果进行分层分析时,也可以看出这两种结果都呈上升趋势。皮尔逊相关分析一致发现抗抑郁药处方流行率与自杀率之间存在正相关。在人群水平上检查了趋势及其相关性。研究结果无法阐明所观察到的关联的因果性质。我们的分析结果一致表明,随着时间的推移,抗抑郁药处方的流行率和自杀率都呈上升趋势,而且两者之间存在正相关。这些发现更新了以前的研究结果,与在人群水平上,开具更多的抗抑郁药处方会导致更低的自杀率的观点相悖。然而,需要承认的是,生态学研究提供的证据不足以推断因果关系。